0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
2006 Views 
0 Saved
0 Vote 1 Contributor2006 Views 0 SavedYou might also be interested in
Dr. S Subramanian, practicing in VS Hospital, Dr. Anita Ramesh at HCG Hospital, and Dr. Saravanan Periasamy in VS Hospital Chennai, are some of the renowned oncologists in Chennai. If you're looking for the best cancer specialists in Chennai, consulting them would be a wise decision. If you're ex....
Dear All, Myelofibrosis & osteopetrosis are two different diseases, According to your symptoms, it points towards Myelofibrosis. It is a rare form of cancer. Please get in touch with our Medical Assistant to evaluate your condition. There are many medical management techniques. Patients b....
There are multiple options available for reconstruction of the breast following breast cancer surgery (oncoplastic breast surgery) but the new form-stable highly cohesive silicone gel implants are a great option for reconstructive surgery. It’s important to understand that there is very little tissu....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.